Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05349487
Other study ID # 20210501
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 28, 2022
Est. completion date June 30, 2025

Study information

Verified date May 2024
Source University of Miami
Contact Jerri Halgowich
Phone 305-243-3818
Email jhalgowich@med.miami.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to evaluate the new Blom-Singer SpeakFree disposable hands free valve heat and moisture exchanger (HME). The investigators will compare the SpeakFree to other modalities of stomal occlusion (digital occlusion and digital depression of an HME) for patients who communicate with a voice prosthesis as determined by patient preference and satisfaction. In addition, the investigators will compare the SpeakFree to other modalities of stomal occlusion as determined by objective measures of speech and voice parameters (maximum phonation time, syllables per breath, minimum/maximum phonation pressures, and a clinician rating of voice quality using a visual analog scale).


Recruitment information / eligibility

Status Recruiting
Enrollment 36
Est. completion date June 30, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants who have undergone a total laryngectomy who have and use a voice prosthesis as their primary form of communication for at least 3 months prior to study enrollment. - Participants must have had at least 2 voice prosthesis management visits from a speech pathologist at the University of Miami prior to study enrollment. - Participants must have fully healed suture lines. - Participants must demonstrate fluent tracheoesophageal speech (i.e., maximum phonation time of at least 5 seconds during 3 consecutive trials) - Current HME use for a minimum of 1 month - Participants willing to complete the survey and provide a signed Informed Consent Form - Males and non-pregnant females over the age of 18 Exclusion Criteria: - Participants who do not have a voice prosthesis. - Participants who have dysarthria. - Participants who are currently receiving treatment for head and neck cancer. - Participants who have an underlying neurologic condition potentially impacting speech.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
SpeakFree HME Hands Free Valve
A voice prosthesis, SpeakFree HME Hands Free Valve, achieved with creation of a tracheoesophageal puncture will be placed over the stoma for 1 month.
Other:
Digital Occlusion
Using participant's own fingers, they will be putting their fingers over the stoma.
Device:
Digital Depression HME
A digital handheld press-down HME will be placed over stoma.

Locations

Country Name City State
United States University of Miami Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Satisfaction as measured by VAS Patient preference and satisfaction will be measured using a visual Analog Scale (VAS) ranging in score from 1-10 with a higher score indicating greater satisfaction with the device. Up to 1 month
Primary Voice Quality: Patient Rating Voice Quality will be measured using a visual Analog Scale ranging in score from 1-10 with a higher score indicating that the patient feels their voice quality is better with the device. Up to 1 month
Secondary Change in Maximum Phonation Time Maximum phonation time (MPT) is a clinical measurement of the longest time a person can phonate a vowel in seconds. Baseline, 1 month
Secondary Change in Syllables Per Breath Participants' number of syllables per breath while reading a standardized reading passage will be measured and reported. Baseline, 1 month
Secondary Pressure Needed to Phonate Minimal and maximal pressures will be reported using a manometer while the participant counts from 1 to 15. Baseline
Secondary Change in Voice Quality: Clinician Rating The clinician will rate participant's voice quality using VAS. VAS has a total score ranging from 1 to 10 with the higher score indicating that the clinician feels that participant's voice quality is better with the device. Baseline, 1 month
See also
  Status Clinical Trial Phase
Completed NCT01089803 - Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer N/A
Completed NCT00026975 - Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients Phase 2
Completed NCT01435252 - A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab Phase 2
Recruiting NCT04174950 - Perioperative ERAS Based Nursing Intervention for Laryngeal Cancer Patients N/A
Recruiting NCT05857202 - Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
Recruiting NCT06077643 - Workshops and Exchange Groups for Laryngectomized Patients
Not yet recruiting NCT06137378 - European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] Phase 2
Active, not recruiting NCT02586207 - Pembrolizumab in Combination With CRT for LA-SCCHN Phase 1
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Recruiting NCT05375266 - Immune Biomarker Study for Head and Neck Cancer
Completed NCT03134976 - Wound Complications in Head and Neck Surgery
Recruiting NCT04650919 - Aortic Laryngeal Rehabilitation Graft N/A
Recruiting NCT05830240 - A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer Early Phase 1
Terminated NCT02437513 - NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration N/A
Completed NCT01633541 - Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Phase 2
Completed NCT01332682 - Resistance Training and Physical Functioning in Head and Neck Cancer Patients Phase 1
Terminated NCT00011492 - Patient Evaluation for Head and Neck Surgery Branch Studies
Completed NCT00467948 - Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients Phase 3
Recruiting NCT06024980 - Using the Subglottic Pressure to Predict the Dysphagia After Partial Laryngectomy N/A
Recruiting NCT03747783 - Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal Cancer